Pulse Biosciences Inc. logo

Pulse Biosciences Inc.

PLSE | NASDAQ
Chart Builder DCF Calculator
$52.37
-$1.50 (-2.78%)
Sep 21, 2026, 11:05 AM ET · Market open

Company Profile

Pulse Biosciences, Inc. is an innovative firm specializing in bioelectric medicine. Their primary offering is the CellFX System, a sophisticated, console-based platform that is precisely controlled via software. This system utilizes its proprietary Nano-Pulse Stimulation technology to deliver extremely brief, nanosecond-duration electrical pulses. This advanced method is designed to selectively eliminate target cells without thermal damage, effectively safeguarding adjacent non-cellular tissue. The CellFX System is applied in the treatment of various medical conditions. The company, originally incorporated in 2014 as Electroblate, Inc., officially became Pulse Biosciences, Inc. in December 2015. Its corporate headquarters are situated in Hayward, California.

Key Executives

Name Position
Paul Arthur LaViolette President, Chief Executive Officer & Co-Chairman of the Board
Darrin R. Uecker Chief Technology Officer & Director
Jon Skinner Chief Financial Officer
Liane Teplitsky Chief Operating Officer
David Danitz Senior Vice President of Engineering
Gansevoort Dunnington Chief Medical Officer
Kenneth Stratton General Counsel & Corporate Secretary
Niv Ad Chief Science Officer of Cardiac Surgery
Patty Perla Vice President of Human Resources
Steven T. Weber Vice President of Accounting, Principal Accounting Officer & Global Corporate Controller

Latest SEC Filings

Date Type Title
Sep 02, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 28, 2026 4 Filing
Aug 28, 2026 3 Filing
Aug 28, 2026 4 Filing
Aug 28, 2026 3 Filing
Aug 06, 2026 8-K Current Report
Aug 06, 2026 424B5 Filing
Aug 06, 2026 10-Q Quarterly Report
Aug 06, 2026 8-K Current Report
View All SEC Filings
Pulse Biosciences Inc.
Pulse Biosciences Inc. logo
Country United States
IPO Date May 17, 2016
Industry Medical - Instruments & Supplies
Sector Healthcare
Employees 116
CEO Paul Arthur LaViolette

Contact Details

601 Brickell Key Drive Miami, Florida 33131 United States

Stock Details

Ticker Symbol PLSE
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
CIK Code 0001625101
CUSIP Number 74587B101
ISIN Number US74587B1017
SIC Code 3841

© 2026 bestshares.com. All rights reserved.